DK0647131T3 - Dermatikum til understøttelse af oxygentransporten i huden - Google Patents

Dermatikum til understøttelse af oxygentransporten i huden

Info

Publication number
DK0647131T3
DK0647131T3 DK93912636.3T DK93912636T DK0647131T3 DK 0647131 T3 DK0647131 T3 DK 0647131T3 DK 93912636 T DK93912636 T DK 93912636T DK 0647131 T3 DK0647131 T3 DK 0647131T3
Authority
DK
Denmark
Prior art keywords
skin
pct
oxygen
dermatological
fluorocarbon
Prior art date
Application number
DK93912636.3T
Other languages
English (en)
Inventor
Leonhard Zastrow
Udo Gross
Klaus Stanzl
Joachim Roeding
Original Assignee
Lancaster Group Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group Ag filed Critical Lancaster Group Ag
Application granted granted Critical
Publication of DK0647131T3 publication Critical patent/DK0647131T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93912636.3T 1992-06-26 1993-06-24 Dermatikum til understøttelse af oxygentransporten i huden DK0647131T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221268A DE4221268C2 (de) 1992-06-26 1992-06-26 Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut

Publications (1)

Publication Number Publication Date
DK0647131T3 true DK0647131T3 (da) 1996-01-08

Family

ID=6462055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93912636.3T DK0647131T3 (da) 1992-06-26 1993-06-24 Dermatikum til understøttelse af oxygentransporten i huden

Country Status (21)

Country Link
US (1) US5637318A (da)
EP (1) EP0647131B1 (da)
JP (1) JP3599112B2 (da)
AT (1) ATE131040T1 (da)
AU (1) AU668399B2 (da)
CA (1) CA2138974C (da)
CZ (1) CZ283657B6 (da)
DE (2) DE4221268C2 (da)
DK (1) DK0647131T3 (da)
ES (1) ES2083286T3 (da)
FI (1) FI110841B (da)
GR (1) GR3018338T3 (da)
HK (1) HK1002699A1 (da)
HU (2) HUT68947A (da)
IL (1) IL105945A (da)
NO (1) NO306974B1 (da)
NZ (1) NZ252999A (da)
PL (1) PL172326B1 (da)
SK (1) SK279824B6 (da)
WO (1) WO1994000109A1 (da)
ZA (1) ZA934571B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2204777A1 (en) * 1994-11-15 1996-05-23 Steven Scott Porter Skin care compositions and methods
DE19715478A1 (de) * 1997-04-10 1998-10-15 Lancaster Group Gmbh Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen
DE19734547B4 (de) 1997-08-01 2004-08-19 Lancaster Group Gmbh Kosmetische Zusammensetzungen mit agglomerierten Substraten
DE19861012A1 (de) 1998-03-18 1999-09-30 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
US6302863B1 (en) 1998-06-16 2001-10-16 Nikolai Tankovich Method for removal of lipids via a perfluorocarbon tumescent solution
WO2000041671A2 (en) * 1999-01-12 2000-07-20 T & T Pharmaceuticals, Ltd. Composition, device, and method for subcutaneous fat removal
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
DE10106288A1 (de) * 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
US7357937B2 (en) 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
EP1562557B2 (en) * 2002-11-01 2016-11-16 University of Medicine and Dentistry of New Jersey Geodate delivery vehicles
DE10257240B4 (de) * 2002-12-04 2005-03-10 Coty Bv Kosmetische Zusammensetzung mit elektrischen Ladungsträgern und deren Verwendung
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
DE10342449A1 (de) * 2003-09-13 2005-04-07 Beiersdorf Ag Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
DE10358306B8 (de) * 2003-12-08 2005-03-03 Coty B.V. Kosmetisches und dermatologisches Sauerstoff-Trägersystem, Verfahren zu dessen Herstellung sowie seine Verwendung
DE102004039459B4 (de) 2004-08-10 2011-06-16 Lancaster Group Gmbh Kosmetischer Wirkstoffkomplex zur Hautregenerierung
DE102004039631A1 (de) 2004-08-11 2006-03-02 Lancaster Group Gmbh Pigmenthaltiges kosmetisches Mittel mit Anti-Alterungswirkung für die Haut
DE102004048987B3 (de) 2004-10-04 2005-12-15 Coty Deutschland Gmbh Kühlende kosmetische Zusammensetzung und deren Verwendung
DE102006008920B3 (de) 2006-02-21 2007-08-09 Lancaster Group Gmbh Kosmetisches Sonnenschutzprodukt auf Basis von W/Si-Emulsionen
WO2007134304A1 (en) * 2006-05-15 2007-11-22 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
DE102006058394B3 (de) 2006-12-07 2008-06-26 Coty Prestige Lancaster Group Gmbh Hautbräunungs-Basisformulierung mit DHA
DE102007004916A1 (de) 2007-01-26 2008-07-31 Coty Prestige Lancaster Group Gmbh Antifalten-Kosmetikum auf Basis von Peptiden
DE102007010861B4 (de) 2007-03-01 2008-11-20 Coty Prestige Lancaster Group Gmbh Kosmetisches Lichtschutzmittel
DE102007024138A1 (de) 2007-05-23 2008-11-27 Coty Prestige Lancaster Group Gmbh Kosmetisches Hautreinigungsmittel
DE102008008473A1 (de) 2008-02-07 2009-08-13 Coty Prestige Lancaster Group Gmbh Hauttönungsmittel mit DHA auf Basis Wasser-Wachs-Öl
EP2252333A4 (en) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc WOUND AND GAS TISSUE TREATMENTS
DE102008014289A1 (de) 2008-03-11 2009-09-17 Coty Prestige Lancaster Group Gmbh Kosmetikum mit Anti-Alterungswirkung
CA2719658C (en) 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
FR2930727B1 (fr) * 2008-04-30 2012-10-05 Evolution Dermatologique Lab Composition pour le traitement des etats seborrheiques.
AU2009271530B2 (en) * 2008-07-18 2016-01-07 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US20110229575A1 (en) * 2008-09-19 2011-09-22 Clauson Gary L Deep immersion flotation therapy for burn victims
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
WO2010080554A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP3695835A1 (en) 2009-02-03 2020-08-19 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
CA2756685C (en) * 2009-04-15 2019-12-24 Oxygen Biotherapeutics, Inc. Emulsions of perfluorocarbons
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II
ES2702490T3 (es) 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Bacterias probióticas para el tratamiento tópico de trastornos de la piel
TW201321022A (zh) 2011-08-16 2013-06-01 Kate Somerville 供皮膚回春之組合物及方法
EP3148569B1 (en) 2014-05-30 2022-07-06 Azitra, Inc. Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
WO2017087640A1 (en) 2015-11-19 2017-05-26 Baum Marc M Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems
EP3638369A4 (en) 2017-06-16 2021-03-17 Azitra, Inc. COMPOSITIONS AND METHODS OF TREATING NETHERTON'S SYNDROME WITH LEKTI-EXPRESSING RECOMBINANT MICROBES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2070429B (en) * 1979-06-25 1984-05-02 Suntech Use of perfluorocarbon as burn treatment
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
DE3269611D1 (en) * 1981-07-02 1986-04-10 Hoffmann La Roche Process for preparing liposome solutions
GR78151B (da) * 1982-04-05 1984-09-26 Alcon Lab Inc
DE3390172T1 (de) * 1982-08-17 1984-11-29 Sun Tech, Inc., Philadelphia, Pa. Perfluorkohlenstoff-Emulsionen, deren Herstellung und deren Verwendung in der Therapie
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
JPH01503146A (ja) * 1986-09-19 1989-10-26 ケメックス　ファーマシューティカルズ，インコーポレイティド 身体組織の治療方法および身体組織への医薬の投与方法
US5219538A (en) * 1987-03-13 1993-06-15 Micro-Pak, Inc. Gas and oxygen carrying lipid vesicles
ES2030494T3 (es) * 1987-06-23 1992-11-01 Eniricerche S.P.A. Composicion de una fase conteniendo un aceite perfluorado y uno o varios agentes superficiactivos, util como excipiente para formulaciones cosmeticas y dermatologicas, asi como para aplicaciones biomedicinales.
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
WO1989008459A1 (en) * 1988-03-11 1989-09-21 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
WO1991000110A1 (en) * 1989-07-05 1991-01-10 Alliance Pharmaceutical Corp. Fluorocarbon emulsions having saturated phospholipid emulsifiers
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
US5246703A (en) * 1991-12-27 1993-09-21 Dow Corning Corporation Siloxy-functional cyclopolysiloxanes

Also Published As

Publication number Publication date
ATE131040T1 (de) 1995-12-15
CA2138974A1 (en) 1994-01-06
IL105945A0 (en) 1993-10-20
EP0647131A1 (de) 1995-04-12
IL105945A (en) 1997-07-13
HU211273A9 (en) 1995-11-28
US5637318A (en) 1997-06-10
CZ283657B6 (cs) 1998-05-13
DE59301122D1 (de) 1996-01-18
JP3599112B2 (ja) 2004-12-08
DE4221268A1 (de) 1994-01-05
NO944959L (no) 1994-12-21
CA2138974C (en) 2006-01-03
FI946056A0 (fi) 1994-12-23
GR3018338T3 (en) 1996-03-31
SK156794A3 (en) 1995-07-11
FI110841B (fi) 2003-04-15
SK279824B6 (sk) 1999-04-13
NZ252999A (en) 1997-06-24
NO944959D0 (no) 1994-12-21
DE4221268C2 (de) 1997-06-12
HUT68947A (en) 1995-08-28
AU4307893A (en) 1994-01-24
ES2083286T3 (es) 1996-04-01
ZA934571B (en) 1994-01-31
CZ326694A3 (en) 1995-07-12
FI946056A (fi) 1994-12-23
PL172326B1 (en) 1997-09-30
EP0647131B1 (de) 1995-12-06
HU9403737D0 (en) 1995-02-28
NO306974B1 (no) 2000-01-24
WO1994000109A1 (de) 1994-01-06
HK1002699A1 (en) 1998-09-11
JPH07508006A (ja) 1995-09-07
AU668399B2 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
DK0647131T3 (da) Dermatikum til understøttelse af oxygentransporten i huden
DE59301123D1 (de) Galenische zusammensetzung für die topische anwendung.
DK0645997T3 (da) Kosmetisk præparat indeholdende phospholipider og fluorcarboner
ATE252367T1 (de) Verfahren und regelung des hautaussehens mit vitamin - b3 - verbindungen
ZA9811926B (en) High glycerin containing anti-microbial cleansers.
DE59703511D1 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
ATE355058T1 (de) Verfahren zur behandlung von akne vulgaris mit einer avermectin-verbindung
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
NO304575B1 (no) Preparater inneholdende en fluorkarbonemulsjon og anvendelse av disse som kosmetiske eller dermatiske midler
BR9810711A (pt) Formulação tópica de pulverização antipruriginosa, e, processo para prevenção ou tratamento de prurido em um paciente
KR910021238A (ko) 켈로이드 치료제
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung